Connect with us

Biotech

Extremadura Awards the Supply of Laparoscopic Surgery Equipment to Medtronic

Extremadura has divided the execution of the contract into four annual payments. Two of these correspond to six months of 2021 and 2024, respectively, and the rest correspond to the whole of 2022 and 2023. In order to determine the time interval, the nature of the services included in the award has been taken into account, as well as the continuity in time of the health needs of the center.

Published

on

Extremadura updates healthcare technology in the Plasencia Health Area. The sectorial management of this area has awarded the supply of laparoscopic surgery equipment to Medtronic for $2.94 million (€2.6 million), according to the community’s contractor profile.

The object of the contract is the supply of laparoscopic surgery equipment for the operating rooms of the Virgen del Puerto Hospital in Plasencia. In addition, the contract includes a 10% equivalent to the concept of transfer of the necessary machinery for its operation and the integral maintenance during the execution of the contract.

The administration has only received the offer of Medtronic, a company that will have to deposit a guarantee equivalent to 5% of the total amount of the contract. On the other hand, the award has a three-year execution period.

Read more about the contract for the supply of laparoscopic surgery equipment, for $2.94 million (€2.6 million), that Extremadura has closed with Medtronic, and find other important financial news with our companion app, Born2Invest.

Extremadura has divided the execution of the contract into four annual payments

In order to determine the time interval, the nature of the services included in the award has been taken into account, as well as the continuity in time of the health needs of the center. The regional administration considers the period established as “adequate and sufficient for its correct execution”, according to the justification report.

To determine the amount, the current prices being applied in the different areas of the Extremadura Health Service (SES) have been taken into account, which are considered to be “adjusted to the general market price.”

SEE ALSO  The real risks of retirement investing

The execution of the contract is divided into four annual payments. Two of these correspond to six months of 2021 and 2024, respectively, and the rest correspond to the whole of 2022 and 2023. The six months of the first and last year of the contract has an amount of $491,327 (€433,977). On the other hand, for 2022 and 2023 there is an amount of $826,783 (€730,277).

The current prices being applied in the different areas of the Extremadura Health Service (SES) have been taken into account

A month ago, the Government of the Junta put out to tender the construction of a concrete bunker for the radiotherapy unit and control room in this hospital in Extremadura for one million euros. This equipment of the Virgen del Puerto serves the health areas of Plasencia, Navalmoral de la Mata, Coria and eventually Cáceres.

This means covering more than 200,000 inhabitants, according to data provided by the SES. In this case, the contract execution period is ten months. The regional government officials have determined the need to build a new bunker to house the latest generation equipment acquired through the framework agreement signed between the Junta de Extremadura and the Amancio Ortega Gaona Foundation (FAO).

__

(Featured image by newarta via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Olivia McCall is passionate about education, women and children’s rights, and the environment. A long-time investor, she covers news about the latest stocks (lately marijuana and tech), IPOs and indices, and is always on the lookout for socially responsible startups. She also writes about the food sector, and has a keen interest on cryptocurrencies.